Modafinil elicits sympathomedullary activation

Hypertension

Volumn 45, Issue 4, 2005, Pages 612-618

  Taneja, Indu ^a   Diedrich, Andre ^a   Black, Bonnie K ^a   Byrne, Daniel W ^a   Paranjape, Sachin Y ^a   Robertson, David ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Baroreflex; Blood pressure; Catecholamines; Heart rate; Norepinephrine

Indexed keywords

ADRENALIN; CREATININE; MODAFINIL; NORADRENALIN; PLACEBO; POTASSIUM; SODIUM;

ADRENALIN BLOOD LEVEL; ADRENALIN URINE LEVEL; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FATIGUE; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; MALE; NORADRENALIN URINE LEVEL; NORMAL HUMAN; PERONEUS NERVE; POTASSIUM BALANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BALANCE; STANDING; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS;

ADRENAL MEDULLA; ADULT; BENZHYDRYL COMPOUNDS; CARDIOVASCULAR SYSTEM; CATECHOLAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DIURESIS; DOUBLE-BLIND METHOD; ELECTROLYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; REFERENCE VALUES; SYMPATHETIC NERVOUS SYSTEM;

EID: 15744379755     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000158267.66763.63     Document Type: Article

References (36)

1. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol. 1998;43:88-97.
2. O'Connor A. Wakefulness finds a powerful ally. The New York Times. 2004, 4 AD Jun 29; section F, column 2, Health & Fitness;1:D1-D6.
3. Grzesk G, Polak G, Grabczewska Z, Kubica J. Myocardial infarction with normal coronary arteriogram: the role of ephedrine-like alkaloids. Med Sci Monit. 2004;10:CS15-CS21.
4. Lai TI, Hwang JJ, Fang CC, Chen WJ. Methylene 3,4 dioxymethamphetamine- induced acute myocardial infarction. Ann Emerg Med. 2003;42:759-762.
5. Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med. 1978;298:181-186.
6. Muller U, Steffenhagen N, Regenthal R, Bublak P. Effects of modafinil on working memory processes in humans. Psychopharmacology (Berl). 2004;177:161-169.
7. Makris AP, Kelly TH, Rush CR, Wilson JF, Frederich RC. The effects of modafinil on food intake, verbal reports of drug effect, performance, and cardiovascular activity in normal, healthy men and women. Obes Res. 2001;9:181S.
8. Crabbe JB, Rogers NL, Szuba MP, Dinges DF. Modafinil does not affect heart rate or heart rate variability from 0800 to 1200 hours during 88 hours of simulated sustained operations. Sleep. 2003;26:A173-A174.
9. Florence G, Bonnier R, Plagnes D, Pierard C, Satabin P, Peres M, Lagarde D. Effect of modafinil on cerebral blood flow of anesthetized rats. Comparison with amphetamine. Exp Brain Res. 2000;135:552-556.
10. Heitmann J, Cassel W, Grote L, Bickel U, Hartlaub U, Penzel T, Peter JH. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clin Pharmacol Ther. 1999;65:328-335.
11. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000;14:53-60.
12. Makris AP, Rush CR, Frederich RC, Kelly TH. Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite. 2004;42:185-195.
13. Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, Grebow P. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol. 1999;39:281-288.
14. Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet. 2003;42:123-137.
15. Robertson D, Hollister AS, Biaggioni I, Netterville JL, Mosqueda-Garcia R, Robertson RM. The diagnosis and treatment of baroreflex failure. N Engl J Med. 1993;329:1449-1455.
16. Diedrich A, Jordan J, Tank J, Shannon JR, Robertson R, Luft FC, Robertson D, Biaggioni I. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens. 2003;21:1677-1686.
17. Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003;305:800-811.
18. Holmes C, Eisenhofer G, Goldstein DS. Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl. 1994;653:131-138.
19. Watenpaugh DE, Breit GA, Buckley TM, Ballard RE, Murthy G, Hargens AR. Human cutaneous vascular responses to whole-body tilting, Gz centrifugation, and LBNP. J Appl Physiol. 2004;96:2153-2160.
20. Low PA. Laboratory evaluation of clinical autonomic disorders. In: Low PA, ed. Clinical Autonomic Disorders: Evaluation and Management. Philadelphia, Pa: Lippincott-Raven; 1997:179-208.
21. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919-957.
22. Wallin BG, Nerhed C. Relationship between spontaneous variations of muscle sympathetic activity and succeeding changes of blood pressure in man. J Auton Nerv Syst. 1982;6:293-302.
23. Lyons TJ, French J. Modafinil: the unique properties of a new stimulant. Aviat Space Environ Med. 1991;62:432-435.
24. Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol. 1993;16:46-53.
25. Laffont F, Mayer G, Minz M. Modafinil in diurnal sleepiness: a study of 123 patients. Sleep. 1994;17:S113-S115.
26. Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton W, Eldon R, Markland C, Grebow P. Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol. 1998;38:971-978.
27. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Oates JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation. 1979;59:637-643.
28. Frolund L, Kehlet H, Christensen NJ, Albert KG. Effect of ketone body infusion on plasma catecholamine and substrate concentrations during acute hypoglycemia in man. J Clin Endocrinol Metab. 1980;50:557-559.
29. Robertson D, Haile V, Perry SE, Robertson RM, Phillips JA, III, Biaggioni I. Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension. 1991;8:1-8.
30. Tuncel M, Wang Z, Arbique D, Fadel PJ, Victor RG, Vongpatanasin W. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation. 2002;105:1054-1059.
31. Joyner MJ, Dietz NM. Sympathetic vasodilation in human muscle. Acta Physiol Scand. 2003;177:329-336.
32. Wortsman J. Role of epinephrine in acute stress. Endocrinol Metab Clin North Am. 2002;31:79-106.
33. Jacob G, Costa F, Vincent S, Robertson D, Biaggioni I. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration. Circulation. 2003;107:2475-2479.
34. Grassi G, Seravalle G, Turn C, Mancia G. Sympathetic nerve traffic responses to surgical removal of pheochromocytoma. Hypertension. 1999;34:461-465.
35. Goldstein DS, Numberger J Jr, Simmons S, Gershon ES, Polinsky R, Keiser HR. Effects of injected sympathomimetic amines on plasma catecholamines and circulatory variables in man. Life Sci. 1983;32: 1057-1063.
36. Joyce PR, Nicholls MG, Donald RA. Methylphenidate increases heart rate, blood pressure and plasma Epi in normal subjects. Life Sci. 1984; 34:1707-1711.